Arcadia Biosciences, Inc.
202 Cousteau Place
140 articles with Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc. announced the U.S. Patent and Trademark Office has awarded the company a patent for reduced gluten grains.
Arcadia Biosciences, Inc. (Nasdaq: RKDA), a food ingredient company and proven leader in agricultural innovation, improving the quality and nutritional content of crops, today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase of 1,318,828 shares of its common stock, at a purchase price per share of $7.5825,
Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, announced today that it will be presenting at the 21st Annual Global Investment Conference, sponsored by H.C. Wainwright & Co. LLC.
Arcadia Biosciences, Inc. announced that Raj Ketkar, president and CEO, will retire effective September 1, 2019.
Arcadia Biosciences Enters Global Collaboration with Arista Cereal Technologies and Bay State Milling Company for Commercialization of High Fiber Wheat
Arcadia Biosciences, Inc. announced a binding term sheet agreement with Arista Cereal Technologies and Bay State Milling Company for commercialization of its high fiber resistant starch wheat in key wheat markets, including North America, Europe and parts of Asia.
Arcadia Biosciences, Inc. announced its plan to release its second-quarter 2019 financial and business results after market close on August 14, 2019.
Arcadia Biosciences Announces Date of Second-Quarter 2019 Financial Results and Business Highlights Conference Call
Arcadia Biosciences, Inc. announced its plan to release its second-quarter 2019 financial and business results after market close on August 7, 2019.
Arcadia Biosciences Announces Closing of $7.5 Million Registered Direct Offering Priced At-the-Market
Net Proceeds to Fuel Hemp Research, Innovation and Scale-Up of GoodWheat™
Company launches new business unit, Arcadia Specialty Genomics™, to apply its advanced plant breeding and gene editing expertise to cannabis
Arcadia Biosciences Announces Date of First-Quarter 2019 Financial Results and Business Highlights Conference Call
Plans to release its first-quarter 2019 financial and business results after market close on May 8, 2019.
4/12/2019Biopharma companies tap new hires to assume roles in leadership positions, with additions at Metrion, JDRF, Ribometrix, and more.
Experienced R&D strategist brings deep expertise in advanced breeding and gene editing technologies
Arcadia Biosciences Announces Fourth-Quarter and Full-Year 2018 Financial Results and Business Highlights
Arcadia Biosciences, Inc. (Nasdaq: RKDA), a food ingredient company and proven leader in agricultural innovation, improving the quality and nutritional content of crops, today released its financial and business results for the fourth quarter and full year of 2018.
Highly favorable response to pre-commercial introduction of HB4 technology
Arcadia Biosciences, Inc. announced that it will be featured as a presenting company at The Spring Investor Summit.
SONOVA GLA offers cat food manufacturers a sustainable, plant-based source of essential omega-6 fatty acid
The company’s new cannabis-dedicated operating unit, Arcadia Specialty Genomics, will commence research this April with a new 10-acre hemp cultivation facility.
Arcadia Biosciences, a Leader in Advanced Agricultural Breeding and Gene Optimization, Announces New Business Unit Dedicated to Cannabis
Arcadia Specialty Genomics to bring standardization and optimization to America’s cannabis crop with a focus on improved plant quality, resiliency and yield.
Winter planting expands acres and builds supply for commercial launch
Arista Cereal Technologies Announces Dismissal of Patent Dispute With Arcadia Biosciences Over High Fiber Wheat
Arista Cereal Technologies Pty Ltd (ARISTA) announces that the lawsuit initiated by Arcadia Biosciences Inc. against ARISTA in the District Court for the Southern District of New York (SDNY) has been dismissed.